Lauren Feldman 12/09/2022 at 4:09 pm
The Scientist (December 8, 2022) Cell Culture Conquests: Finding and Defeating the Invisible Enemy
Cutting-edge reagents, kits, and techniques provide a robust solution to cell culture mycoplasma contamination.
Genetic Engineering and Biotechnology News (December 8, 2022) Heart Attacks Mimicked on a Chip
Scientists at the University of Southern California Alfred E. Mann Department of Biomedical Engineering say they have developed a “heart attack on a chip,” a device that could one day serve as a method for developing new heart drugs and even personalized medicines.
Reuters (December 6, 2022) Exclusive: Musk’s Neuralink faces federal probe, employee backlash over animal tests
Elon Musk’s Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations amid internal staff complaints that its animal testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations.
Drug discovery, a process which aims to develop new medications and therapeutics, has long been a costly and time-consuming process. The return on impact, however, is projected to be high. Business Insider asked investors with biotech expertise for the startups that are set to take off. This article lists what they said. (PDF attached)
Genetic Engineering and Biotechnology News (December 2, 2022) 3D Organoid Model Developed for Gastroesophageal Junction Cancer
Scientists at Johns Hopkins Medicine and colleagues say they have created a lab-grown organoid model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop at the gastroesophageal junction.
- You must be logged in to reply to this topic.